| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |